Founders Capital Management (Texas)’s Bristol-Myers Squibb BMY Stock Holding History

Founders Capital Management (Texas)’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$86.4K	Hold	1,500	–	–	0.04%	107
2026 Q1	$91K	Hold	1,500	–	–	0.04%	94
2025 Q4	$80.9K	Hold	1,500	–	–	0.04%	100
2025 Q3	$67.7K	Buy	1,500 +300	+25%	+$14K	0.04%	110
2025 Q2	$55.5K	Hold	1,200	–	–	0.03%	125
2025 Q1	$73.2K	Hold	1,200	–	–	0.05%	100
2024 Q4	$67.9K	Hold	1,200	–	–	0.04%	114
2024 Q3	$62.1K	Hold	1,200	–	–	0.04%	125
2024 Q2	$49.8K	Hold	1,200	–	–	0.03%	140
2024 Q1	$65.1K	Buy	1,200 +100	+9%	+$5.09K	0.04%	118
2023 Q4	$56.4K	Buy	1,100 +100	+10%	+$5.25K	0.04%	128
2023 Q3	$58K	Hold	1,000	–	–	0.04%	122
2023 Q2	$64K	Hold	1,000	–	–	0.05%	125
2023 Q1	$69K	Hold	1,000	–	–	0.05%	115
2022 Q4	$72K	Hold	1,000	–	–	0.05%	105
2022 Q3	$71K	Hold	1,000	–	–	0.06%	103
2022 Q2	$77K	Buy	1,000 +1	+0.1%	+$76	0.06%	100
2022 Q1	$62K	Hold	999	–	–	0.04%	111
2021 Q4	$62K	Buy	999 +100	+11%	+$5.87K	0.04%	111
2021 Q3	$53K	Buy	899 +400	+80%	+$26.3K	0.04%	117
2021 Q2	$33K	Hold	499	–	–	0.02%	150
2021 Q1	$32K	Hold	499	–	–	0.02%	138
2020 Q4	$31K	Buy	+499	New	+$30.7K	0.02%	145
2020 Q1	$28K	Hold	499	–	–	0.03%	126
2019 Q4	$32K	Hold	499	–	–	0.02%	142
2019 Q3	$25K	Sell	499 -701	-58%	-$32.9K	0.02%	161
2019 Q2	$54K	Hold	1,200	–	–	0.05%	107
2019 Q1	$57K	Hold	1,200	–	–	0.05%	102
2018 Q4	$62K	Hold	1,200	–	–	0.07%	92
2018 Q3	$74K	Hold	1,200	–	–	0.06%	94
2018 Q2	$66K	Sell	1,200 -41,159	-97%	-$2.22M	0.06%	104
2018 Q1	$2.68M	Hold	42,359	–	–	2.26%	12
2017 Q4	$2.6M	Hold	42,359	–	–	2.15%	15
2017 Q3	$2.7M	Sell	42,359 -28	-0.1%	-$1.64K	2.24%	12
2017 Q2	$2.36M	Buy	42,387 +3,395	+9%	+$185K	2.09%	16
2017 Q1	$2.12M	Buy	+38,992	New	+$2.14M	1.91%	18

Other funds holding BMY

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Founders Capital Management (Texas)'s BMY Position: Q2 2026 in Review

Founders Capital Management (Texas) held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 1,500 shares worth $86.4K. The position accounts for 0.04% of the portfolio, ranked #107.

Founders Capital Management (Texas) first reported a position in BMY in Q1 2017 and has held it in 36 quarters since. The position peaked at $2.7M in Q3 2017. 796 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Founders Capital Management (Texas) held 1,500 shares of Bristol-Myers Squibb worth $86.4K as of Q2 2026.
Founders Capital Management (Texas) left its Bristol-Myers Squibb share count unchanged in Q2 2026.
Bristol-Myers Squibb made up 0.04% of Founders Capital Management (Texas)'s portfolio in Q2 2026, its #107 holding.
Founders Capital Management (Texas) first reported a position in Bristol-Myers Squibb in Q1 2017 and has held it in 36 quarters since.
Founders Capital Management (Texas)'s Bristol-Myers Squibb position peaked at $2.7M in Q3 2017.
796 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Founders Capital Management (Texas)'s 13F filing for Q2 2026, filed 21 Jul 2026.